FIELD: medicine. SUBSTANCE: method involves determining fibrin clot lysis. Fibrin monomer is used when taken in concentration of 1.0-1.9 g/l as fibrin clot formation source. EFFECT: accelerated procedure. 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTING PLASMINOGEN | 2000 |
|
RU2189590C2 |
| METHOD OF INDUSTRIAL PRODUCTION OF FIBRIN-MONOMER FROM BLOOD PLASMA | 2012 |
|
RU2522237C2 |
| METHOD FOR DETERMINATION OF FIBRIN MONOMER SELF-ASSEMBLY TIME | 2007 |
|
RU2366955C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING FACTOR VIIA AND FACTOR XIII | 2001 |
|
RU2272648C2 |
| METHOD FOR DETERMINING FIBRINOGEN DURING RECALCIFICATION OF CITRATE PLASMA AND EVALUATING ITS FUNCTIONALITY | 2019 |
|
RU2703541C1 |
| METHOD OF DETERMINING OXIDATIVE MODIFICATION OF FIBRINOGEN IN BLOOD PLASMA BY CONTENT OF CARBONYL GROUPS IN FIBRINOUS CLOT | 2014 |
|
RU2595806C2 |
| METHOD OF PRODUCING PLATELET-ENRICHED FIBRIN MATRIX OF VARIOUS SHAPES AND SIZES | 2023 |
|
RU2811233C1 |
| REAGENT KIT FOR DIAGNOSING DEGREE OF NEUROINFLAMMATION | 2018 |
|
RU2698206C1 |
| METHOD FOR UTILIZATION OF FIBRIN SEALING MATERIAL, METHOD OF PREPARING COMPOSITION, COMPOSITIONS, AND KITS | 1993 |
|
RU2143924C1 |
| METHOD OF OBTAINING A PLATELET-RICH FIBRIN MATRIX WITH AN OSTEOREPLACEMENT MATERIAL FIXED IN THE FIBRIN NETWORK OR AN AUTOCRUMB FROM BONE OR CARTILAGE TISSUE | 2023 |
|
RU2802583C1 |
